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Abstract
Age-dependent genetic effects on susceptibility to hypertension have been documented. We
present a novel variance-component method for the estimation of age-dependent genetic effects on
longitudinal systolic blood pressure using 57,827 Affymetrix single-nucleotide polymorphisms
(SNPs) on chromosomes 17-22 genotyped in 2,475 members of the Offspring Cohort of the
Framingham Heart Study. We used the likelihood-ratio test statistic to test the main genetic effect,
genotype-by-age interaction, and simultaneously, main genetic effect and genotype-by-age
interactions (2 degrees of freedom (df) test) for each SNP. Applying Bonferroni correction,
three SNPs were significantly associated with longitudinal blood pressure in the analysis of main
genetic effects or in combined 2-df analyses. For the associations detected using the simultaneous
2-df test, neither main effects nor genotype-by-age interaction p-values reached genome-wide
statistical significance. The value of the 2-df test for screening genetic interaction effects could not
be established in this study.
Background
Systolic blood pressure (SBP) increases with age due to
increased peripheral vascular resistance, which accounts
for increased prevalence of hypertension after age 50 [1].
Age-related effects on SBP may result from genetic effects
or from environmental effects (for example, dietary salt
intake) in the context of genetic susceptibility to
hypertension [2,3]. Failure to account for genotype-by-
age interaction may prevent the identification of genetic
variants influencing blood pressure variation and hyper-
tension susceptibility in populations.
In this paper, we examined the effect of genotype-by-age
interaction on SBP. To this end, we present a novel
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dependent effects on SBP using the longitudinal SBP
data and a subset of the Affymetrix 500 k single-
nucleotide polymorphisms (SNPs) genotyped in the
Framingham Heart Study (FHS) Offspring Cohort.
Methods
Population, study design, and phenotypes
The FHS was started in 1948 as a community-based
cohort study of cardiovascular disease. In 1971, 5,124
subjects were enrolled in the FHS Offspring Cohort.
These individuals were children and spouses of the
children of the Original Cohort. The FHS Offspring
Cohort were followed prospectively, and examined
during four clinical visits [4]. The FHS Offspring Study
protocol was reviewed by the Boston University Medical
Center Institutional Review Board and all participants
gave informed consent [5]. Our study included all
offspring participants whose phenotype and genotype
data were available through the Genetic Analyses Work-
shop 16, Problem 2. We excluded twins (n = 10),
individuals on hypertension treatment or unknown
treatment at Visit 1 (n = 64), and those individuals
with missing SBP measurements at Visit 1 (n = 106). The
study was conducted in accordance with the principles of
the Declaration of Helsinki.
We analyzed genotype-by-age interaction for longitudi-
nal SBP. After being in a seated position for at least
5 minutes, each subject was fitted on the left arm with a
mercury sphygmomanometer and a cuff long enough to
fit the most obese arm. A physician then measured SBP.
SBP measures taken during four consecutive clinical
visits were used for analysis.
Genotyping and quality control
SNPs were genotyped on the Affymetrix GeneChip
Human Mapping 500 k Array Set. Genotyping calls
were made with the BRLMM (Bayesian robust linear
model with Mahalanobis distance classifier) algorithm.
The FHS applied a minimum set of SNP quality control
filters by removing individuals that incorrectly identified
their sex and removing SNPs with Mendelian incon-
sistencies. We also filtered for SNPs not mapped to a
chromosome (chromosome 0) and those not located in
autosomal chromosomes (n = 12,398), duplicate SNPs
(removed those with missing position, n = 1,132), SNPs
with Mendelian inconsistencies, and SNPs with minor
allele frequency (MAF) < 0.01.
Statistical analyses
We developed a powerful and robust variance-compo-
nent method to examine the association between a
quantitative trait and SNPs in the context of longitudinal
data. Our method is based on semiparametric transfor-
mation linear models, which allow arbitrarily distributed
quantitative traits [6]. In simulation studies, this
approach is robust to nonnormality and outliers and
performs as well as parametric methods when the
normality assumption is satisfied. In the presence of
non-normality, our approach is substantially more
powerful than its counterpart with parametric transfor-
mations [7].
We examined genotype-by-age interaction on SBP using
the Offspring FHS data, while allowing for family
structure and the longitudinal cohort component of
the data. Models were adjusted for sex. Specifically, we
implemented the following model:
H Y sex age genotype age genotype a g e () = () + () + () + () +++ ββ β β 123 4 *,
where H is an unknown increasing function and can be
consistently estimated from the data; b1, b2, b3,a n db4
are the sex effect, age effect, main genetic effect, and
genotype-by-age interaction, respectively; a is a random
intercept accounting for the correlations of the repeated
measurements from the same individual; g is a polygenic
random effect accounting for the correlations due to
common genetic factors; and e is an individual-specific
residual error. The random effects are assumed to be
normally distributed. This model consists of two parts,
of which the mean part models the effects of covariates
and the association between SNP genotype and long-
itudinal quantitative traits and their interactions, and the
variance-component part models the correlations among
trait values within a family as well as intra-subject
correlation among multiple measurements per subject.
It is straightforward to include random slope in the
above model. Hypothesis testing was performed using
likelihood-ratio test statistics (LRT). The following
models were tested:
Model 1: E [H(Y)] = b1(sex)+b2(age)
Model 2: E [H(Y)] = b1(sex)+b2(age)+b3(SNP)
Model 3 (Full Model): E [H(Y)] = b1(sex)+b2(age)+
b3(SNP)+b4(age*SNP),
where Y is the longitudinal SBP.
(A1) LRT1: Testing H0: b3 =0v s .H A: b3≠0, compares
Model 2 with Model 1, 1 df
(A2) LRT3: Testing H0: b4 =0v s .H A: b4≠0, compares
Model 3 with Model 2, 1 df
(A3) LRT3: Testing H0: b3 = b4 =0v s .H A: b3≠0o rb4≠0,
compares Model 3 with Model 1, 2 df.
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for (A1), (A2), and (A3) are approximately chi-square
with 1 df, 1 df, and 2 df, respectively.
Results
A total of 2,475 Offspring Cohort participants were
available for analysis. In order to preserve computational
resources, analyses were completed for chromosomes 17-
22 only. This subset was judged to provide sufficient data
for a comparison of genome-wide statistical significance
across three models of interest, but not sufficient for
retrieval of novel variants. Before quality control filter-
ing, a total of 58,033 SNPs were available, including
11,232 for chromosome 17, 14,832 for chromosome 18,
6,350 for chromosome 19, 12,367 for chromosome 20,
7,085 for chromosome 21, and 6,167 for chromosome
22. After implementing quality control filters, a total of
57,827 SNPs remained for analyses: 11,176 for chromo-
some 17, 14,818 for chromosome 18, 6,262 for
chromosome 19, 12,352 for chromosome 20, 7,078 for
chromosome 21, and 6,141 for chromosome 22. FHS
participants were on average 33 years old (SD = 9) at Visit
1 and 54% were women. The mean SBP at first visit was
119 mm Hg (SD = 14). At the last visit, the mean age
was 60 years (SD = 9) and the mean SBP was 126 mm Hg
(SD = 19).
Table 1 and Figure 1 display the results of analysis for the
main genetic effect (LRT1), genotype-by-age interaction
(LRT2), and combined analysis of main genetic and
genotype-by-age interaction (LRT3) on longitudinal SBP.
Three SNPs reached genome-wide statistical significance
for association with longitudinal SBP using a p-value of
8.64 × 10
-7 (Bonferroni correction 0.05/57,827 tests,
negative log base 10 p-value (-log(p)) = 6.0). If
additional correction for the three models was per-
formed, only one SNP association reached statistical
significance (p-value = 2.88 × 10
-7,- l o g ( p) = 6.54).
Of the three SNPs with a -log(p) ≥ 6, one signal
c o r r e s p o n d e dt ot h em a i ng e n e t i ce f f e c t s ,a n dt h e
remaining two signals were for the 2-df test, which
simultaneously estimated the main genetic effect and
genotype-by-age interactions for each SNP. None of the
SNPs obtained a -log(p) ≥ 6 for the 1-df genotype-by-age
analysis.
Discussion
In this paper, we applied a novel variance-component
method for the estimation of age-dependent effects on a
quantitative character (SBP) in the context of Affymetrix
500 k SNPs genotyped in the FHS Offspring Cohort.
Differences in the expression of SBP or differences in
genes contributing to the variation in susceptibility to
hypertension by age are plausible and supported by
several lines of evidence [1,2,8]. First, many studies have
suggested differences in risk of hypertension by age [1,2].
In addition, several studies have reported associations of
blood pressure related phenotypes with candidate gene
polymorphisms or candidate regions that are modified
by age [8-10]. We interrogated the effect of genotype-by-
Table 1: LRT and p-values for the association between SNPs and longitudinal SBP for the main genetic effect (LRT1), genotype-by-age
interaction (LRT2), and combined main effects and genotype-by-age interaction (LRT3)
Genetic effect Genotype-by-age effect Genetic + genotype-by-age effects
SNP
a Chr
b Position Alleles MAF LRT1 -log(p)L R T 2 - l o g ( p)L R T 3 - l o g ( p)
rs17631940 17 30842243 A/G 0.49 23.99 6.01 1.02 0.50 25.00 5.43
rs1476112 18 170690 T/G 0.08 14.40 3.83 13.43 3.61 27.83 6.04
rs8102150 19 922139 G/C 0.03 7.05 2.10 23.09 5.81 30.14 6.55
aOnly SNPs with a Bonferroni-corrected p-value ≤ 10
-7 (-log(p) ≥ 6) in at least one of the tests are shown.
bChr, chromosome; MAF, minor allele frequency.
Figure 1
LRT -log(p) values for the association between SNPs
and longitudinal systolic blood pressure, for the main
genetic effect (LRT1), genotype-by-age interaction
(LRT2), and combined main genetic effects and
genotype-by-age interaction (LRT3).R e s u l t sf o ra l l
SNPs on chromosomes 17-22 are displayed.
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significant interaction in the subset of SNPs in the
sampled chromosomes that were evaluated.
We were able to detect significant main genetic effects for
one SNP, rs17631940, located at the 17q12 region, in
the intron 2 of the schlafen family member 12-like
(SLFN12L) gene (Table 1). The SLFN12L gene product is
involved in cell growth and T cell development [11], and
the gene’s association with blood pressure phenotypes
has not been previously reported. Interestingly, two
significant genome-wide associations were identified
using the 2-df test, but none of the SNPs were
significantly associated in analysis of main genetic effects
or in genotype-by-age interaction. These SNPs were
rs1476112, located on the DKFZP781G0119 gene
(18q22.3 region), and rs8102150, located at the
19q13.33 region and not within a gene. These findings
are intriguing and suggest that genes may influence a
trait by a combination of main and interacting effects.
However, these findings will need to be replicated to
distinguish this signal from a false-positive finding. In
addition, the utility of 2-df test for screening genetic
interaction effects could not be established in this study.
Conclusion
We did not identify SNPs with specific genotype-by-age
interaction effects on SBP. Accounting for interaction
with environmental factors such as age may improve our
ability to detect genetic effects, but some of the effects
may result from a combination of main and environ-
ment interacting genetic effects on phenotypes. The
identification of genetic factors, both in the absence of
and in combination with age effects, that influence the
risk of hypertension, can provide new insights into
susceptibility and contribute important new information
for understanding the mechanistic basis of cardiovascu-
lar disease.
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